Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2023-08-29 Director's Dealing
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 251.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a company director, including acquisitions and disposals of shares and options. The document is a formal notification of insider trading activity by a director, which aligns with the definition of Director's Dealing filings. The document length is about 4752 characters, consistent with a detailed insider trading report rather than a brief announcement or other report types.
2023-08-29 English
Appointment of Non-executive Director 1 page 121.9K
Board/Management Information Classification · 100% confidence The document is an announcement dated 25 August 2023 from Nanosonics Limited regarding the appointment of Dr Larry Marshall as a Non-Executive Director effective 3 October 2023. The content focuses solely on the change in the company's board composition, detailing Dr Marshall's background and qualifications. There is no financial data, report, or regulatory filing referenced beyond the appointment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short and does not contain financial statements or other report types.
2023-08-24 English
Appendix 4E 3 pages 250.7KB
Earnings Release Classification · 95% confidence The document is titled 'Appendix 4E Preliminary Final Report – Results for Announcement to the Market' for the year ended 30 June 2023, which is a standard Australian Securities Exchange (ASX) preliminary final report format. It provides summarized financial results, including revenue, profit, earnings per share, and net tangible asset backing. It explicitly states that the audited Annual Report for the year ended 30 June 2023 accompanies this announcement and that additional detailed financial statements and notes are in the Annual Report. The document is about 6,122 characters long, which is relatively short and mainly serves as a summary announcement of the financial results rather than the full detailed report itself. It references the Annual Report multiple times as the source of detailed financial statements and audit reports. According to the 'Menu vs Meal' rule, this document is an announcement of results and the Annual Report, not the full Annual Report itself. Therefore, it should be classified as an Earnings Release (ER) because it provides initial announcement of the full year financial results with key highlights, but not the full detailed report. FY 2023
2023-08-21 English
2023 Annual Report 112 pages 10.7MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2023' for Nanosonics Limited and contains detailed sections typical of an annual report, including financial highlights, letter to shareholders, financial statements, directors' report, remuneration report, auditor's independence declaration, and independent auditor's report. The content includes comprehensive financial data, operational review, strategic updates, and governance information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2023-08-21 English
2023 Full Year Financial Results 12 pages 439.5KB
Annual Report Classification · 100% confidence The document is titled 'Nanosonics 2023 full year financial results' and dated 22 August 2023. It contains detailed financial data for the fiscal year ended 30 June 2023, including revenue, profit, operating expenses, segment performance, and unit sales. The text includes comprehensive financial statements and analysis, such as revenue breakdowns, profit before tax, gross profit margin, and cash flow figures. The presence of full-year financial results, detailed financial tables, and management commentary indicates this is a comprehensive annual financial report. There is no indication that this is merely an announcement or a summary; the document length (15,000 characters) and content depth confirm it is the full report. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2023
2023-08-21 English
2023 Full Year Financial Results Investor Presentation 44 pages 6.0MB
Investor Presentation Classification · 95% confidence The document is titled '2023 Full Year Results' and is presented as an 'INVESTOR PRESENTATION' by the CEO and CFO. It contains detailed financial results, business highlights, installed base and upgrades, profitability, research and development, ESG, and outlook sections. The content includes revenue figures, growth percentages, and operational metrics for the full fiscal year 2023. The document is about 15,000 characters long, which is substantial and contains detailed financial and operational data. The presence of slides and structured presentation format indicates it is a presentation document rather than a formal annual report or earnings release. The document is clearly intended for investors and focuses on financials, strategy, and market position. Therefore, the most appropriate classification is 'Investor Presentation' (IP).
2023-08-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.